Health Care

Shares of Teva Pharmaceuticals (NYSE: TEVA) fell to a new low this month as markets across the world continued to…

Drugmaker Mylan (NASDAQ: MYL) is all set for a transformation with its planned merger with Upjohn, the generic medicine business…

According to the American Cancer Society, prostate cancer is the second most common form of cancer among men in the US,…

-- Baxter International Inc. (NYSE: BAX) reported Q4 2019 earnings of $0.97 per share, up 37% from last year. --…

Biotech companies all over the world have been trying to find the treatment and vaccine for the coronavirus pandemic since…

10x Genomics, Inc.  (NASDAQ: TXG) Q4 2019 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Carrie Mendivil -- Investor Relations Serge Saxonov -- Chief Executive Officer,…

Veru Inc.  (NASDAQ: VERU) Q1 2020 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Sam Fisch -- Director of Investor Relations Mitchell S. Steiner -- Chairman,…

Align Technology Inc. (NASDAQ: ALGN) stock plunged to a 3-year low of $161.39 on Monday as the global pandemic overshadowed…

-- Catalyst Pharmaceutical (NASDAQ: CPRX) reported its fourth-quarter 2019 earnings of $0.07 per share versus $0.10 per share expected. --…

-- CorMedix Inc. (NYSE: CRMD) reported a fourth-quarter 2019 loss of $0.21 per share versus a loss of $0.24 per…

-- Specialty pharmaceutical company AcelRx Pharmaceuticals (NASDAQ: ACRX) reported fourth quarter 2019 loss of $0.18 per share vs. expected loss of…

-- Achieve Life Sciences (NASDAQ: ACHV) reported Q4 2019 net loss of $3.2 million, or $0.30 per share, compared to…

-- Neos Therapeutics Inc. (NASDAQ: NEOS) reported a fourth-quarter 2019 loss of $0.07 per share versus a loss of $0.03…

For some of the leading drugmakers, currently, the first priority is to find an effective treatment for Covid-19, which was…

-- Biopharmaceutical company Dynavax Technologies Corporation (NASDAQ: DVAX) reported a net loss of $36.8 million $0.44 per share for the…

Novavax Inc. (NASDAQ: NVAX) reported a narrower loss for the fourth quarter of 2019 helped by higher revenue and lower…

PetIQ, Inc.  (NASDAQ: PETQ) Q4 2019 Earnings Conference Call Final Transcript Corporate Participants: Jeff Sonnek -- Senior Vice President, ICR McCord Christensen -- Chief Executive…

-- Avid Bioservices (NASDAQ: CDMO) reported a loss of $0.## per share for its third quarter of 2020 vs. expected…

Image for representation (Photo by Drew Hays on Unsplash) — Sunesis Pharmaceuticals (NASDAQ: SNSS) reported loss of $0.05 per share in the…

-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) reported a net loss of $6.6 million or $0.55 per share for the fourth…

InspireMD Inc. (NYSE: NSPR) reported earnings that matched expectations for the fourth quarter of 2019 while revenues missed estimates. The…